#344 Global Rank Marché Ouvert

Li Ge

Santé & Biotech. Pharmaceuticals.

Fortune Nette (Est.)

$10.6 B
-$237 (-0.00%) Aujourd'hui
Portefeuille : WuXi AppTech ▼ Volatile Wuxi Biologics (Cayman) ▼ Volatile
Li Ge

Photo: Press Agency / 2026

Profil Financier

Li Ge occupe actuellement le rang #344 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $10.6 B (-$237 sur 24h).

Li Ge is the chairman and CEO of Wuxi Apptec, a provider of research and clinical trial services to biotech and pharmaceutical industries worldwide.

Li is also the chairman of biopharma contract research and manufacturing firm WuXi Biologics.

A subsidiary of WuXi Apptec broke ground on a 190-acre pharmaceutical campus in Delaware in 2022.

Li holds a Ph.D. in organic chemistry from Columbia University.

His wife and Wuxi Apptec cofounder Zhao Ning passed away in 2023, at age 56, after battling cancer for 20 years.

The Ge Li & Ning Zhao Family Foundation donated $20 million to Memorial Sloan Kettering Cancer Center in New York in 2020 to help fight lung cancer.

Historique de Fortune (12 Mois)

1A 5A Max
Jan 25 Juin 25 Déc 25 Auj.

Répartition des Actifs

Actif / Société Parts Détenues Valeur Est. Tendance
WuXi AppTech (603259-CN) 226.1M parts $5.6 B Volatile
Wuxi Biologics (Cayman) (2269-HK) 69.1M parts $480 M Volatile